Copyright
©The Author(s) 2022.
World J Clin Cases. May 26, 2022; 10(15): 5025-5035
Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.5025
Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.5025
Ref. | Age (yr)/sex | CMN location | Neurological symptoms | Neurological tumor location | Hydrocephalus | Surgery | Pathology | Chemotherapy/radiotherapy | Follow-up |
Frisoni et al[28] | 20/M | Back, neck, trunk | Weakness of right lower limb | Left pons | No | None | Unknown | None | Unknown |
Vadoud-Seyedi et al[29] | 50/F | Back, neck, trunk, limbs | Depression, intracranial hypertension for 4 mo | Right temporal lobe | Yes | STR | Meningeal melanoma | None | 3 wk, death |
Arunkumar et al[30] | 24/M | Face | Epilepsy for 5 yr | Left frontal lobe, right sphenoid | Yes | STR | Meningeal melanoma | None | 48 h, death |
Peretti-Viton et al[31] | 19/M | Back, hip | Intracranial hypertension for 4 mo | Left fronto- parietal temporal lobe, diffuse | Yes | None | Meningeal melanocytosis | None | 2 mo, death |
Shinno et al[10] | 35/M | Sporadic | Intracranial hypertension for 2 mo | Right fronto- temporal lobe, diffuse | No | VPS | Meningeal melanomatosis | Chemotherapy | 30 mo, death |
de Andrade et al[32] | 21/F | Lower back | Epilepsy started at the age of 7 | Bilateral temporal lobe, pons | No | None | Unknown | None | > 10 yr |
Tartler et al[8] | 36/M | Lower back, hip | Epilepsy for 1 yr | Left temporal lobe | No | STR, VPS | Meningeal melanoma | Radiotherapy, chemotherapy | Unknown |
Kang et al[15] | 29/M | Sporadic | Intracranial hypertension for 3 yr, Dandy-Walker syndrome | Bilateral temporal lobe | No | STR | Meningeal melanocytoma | None | Unknown |
Kiecker et al[11] | 42/M | Head | Right limb weakness, hemianopia, aphasia for 3 wk | Left temporal occipital lobe | No | GTR | Meningeal melanoma | Chemotherapy | 8 mo, relapse |
Chute et al[33] | 43/M | Head, trunk, limbs | Epilepsy for 5 yr | Left temporal lobe | No | None | Meningeal melanoma | None | 5 yr, death |
Zhang et al[34] | 25/M | Abdomen, chest, back | Intracranial hypertension for 4 mo | Diffuse, sulcus | Yes | VPS | Meningeal melanocytosis | None | 4 mo, death |
Walbert et al[6] | 30/F | Sporadic | Epilepsy for 5 yr, Dandy-Walker syndrome | Diffuse | Yes | VPS, GTR | Meningeal melanoma | Radiotherapy, chemotherapy | > 12 mo |
Ge et al[35] | 37/M | Left arm | Intracranial hypertension for 1 yr | Right frontal parietal lobe | No | STR | Meningeal melanoma | None | 8 d, death |
Kurokawa et al[36] | 40/F | Trunk | Left leg feels abnormal and weak for 2 yr | T10 cord | No | GTR | Meningeal melanocytoma | None | > 4 yr |
Oliveira et al[37] | 29/F | Trunk | Epilepsy for 4 mo | Diffuse | No | STR | Meningeal melanomatosis | None | 21 d, death |
Matsumura et al[7] | 44/M | Trunk, lower limbs | Epilepsy, memory loss | Brain and spine, diffuse | Yes | None | Meningeal melanomatosis | Chemotherapy | 6 mo, death |
Bhatia et al[5] | 35/M | Trunk, back | Intracranial hypertension for 6 mo | Brain and spine, diffuse | Yes | VPS | Meningeal melanomatosis | Chemotherapy | Unknown |
Kolin et al[25] | 67/M | Trunk, back | Epilepsy for 6 mo | Meninges, diffuse | Yes | None | Meningeal melanomatosis | Radiotherapy | Unknown |
Ma et al[16] | 34/F | Trunk, abdomen, head, lower limbs | Intracranial hypertension for 1 wk | Left temporal lobe | No | GTR | Meningeal melanoma | None | 22 mo, death |
Alessandro et al[9] | 20/F | Sporadic | Epilepsy for 18 mo | Right temporal lobe, diffuse | Yes | VPS | Meningeal melanocytosis | Chemotherapy | 1 mo, death |
Present report | 41/F | Trunk, back, neck | Intracranial hypertension for 1 mo | Left temporal lobe | No | GTR | Meningeal melanoma | None | 5 mo, death |
Araújo et al[38] | 30/F | Back, left thigh | Impaired vision, intracranial hypertension for 1 wk | Frontal lobe, cervical vertebrae | No | STR | Meningeal melanoma | Radiotherapy | 7 mo, death |
Age (yr) | Sex | Multifocla or diffuse | Hydrocephalus | Tumor resection | Chemotherapy | Radiotherapy | follow up (d) | Vital status |
37 | M | No | No | Yes | No | No | 8 | Dead |
50 | F | No | Yes | Yes | No | No | 21 | Dead |
29 | F | Yes | No | Yes | No | No | 21 | Dead |
20 | F | Yes | Yes | No | Yes | No | 30 | Dead |
19 | M | Yes | Yes | No | No | No | 60 | Dead |
25 | M | Yes | Yes | No | No | No | 120 | Dead |
41 | F | No | No | Yes | No | No | 150 | Dead |
44 | M | Yes | Yes | No | Yes | No | 182 | Dead |
30 | F | Yes | No | Yes | No | Yes | 210 | Dead |
42 | M | No | No | Yes | Yes | No | 240 | Alive |
30 | F | Yes | Yes | Yes | Yes | Yes | 365 | Alive |
34 | F | No | No | Yes | No | No | 660 | Dead |
35 | M | Yes | No | No | Yes | No | 900 | Dead |
40 | F | No | No | Yes | No | No | 1460 | Alive |
21 | F | Yes | No | No | No | No | 1825 | Alive |
43 | M | No | No | No | No | No | 1825 | Dead |
Variables | P value |
Sex | 0.669 |
Multifocal or diffuse | 0.752 |
Hydrocephalus | 0.086 |
Tumor resection | 0.788 |
Chemotherapy | 0.636 |
Radiotherapy | 0.614 |
- Citation: Liu BC, Wang YB, Liu Z, Jiao Y, Zhang XF. Neurocutaneous melanosis with an intracranial cystic-solid meningeal melanoma in an adult: A case report and review of literature. World J Clin Cases 2022; 10(15): 5025-5035
- URL: https://www.wjgnet.com/2307-8960/full/v10/i15/5025.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i15.5025